2 completed, 2 enrolling by invitation, 1 not yet recruiting, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Nasal Surgical Procedures: new trials by email Literature Review of Nasal Surgical Procedures trials Research Report on Nasal Surgical Procedures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery Remimazolam - Emergence Agitation, General Anesthesia | Phase 4 | Not yet recruiting | Jeju National University School of Medicine | 138 | 2026-07-24 | 2026-07-31 |
| Evaluation of a Novel Nasal Conformer in Pediatric Patients use of an anatomically designed nasal conformer - Cleft Lip, Nasal Surgical Procedures | Phase 2 | Enrolling by invitation | East Tennessee Children's Hospital | 20 | 2025-06-01 | 2026-09-16 |
| Regenerative Medicine Approach to Nasal Reconstruction 3D Nasal Reconstruction Planning - Nasal Surgical Procedures, Regenerative Medicine | Not applicable | Completed | Mayo Clinic | 7 | 2022-05-18 | 2025-07-02 |
| Antibiotic Prophylaxis in Rhinoplasty Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg., Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4 hours) or "clindamycin" 150mg(every 6 hours) for 3 days - Nasal Obstruction, Nasal Surgical Procedures | Phase 3 | Enrolling by invitation | Stanford University | 864 | 2020-05-20 | 2026-04-24 |
| Chronic Rhinosinusitis Classification Proposal No intervention - RHINOPLASTY, NASAL SURGICAL PROCEDURES | Completed | Fondation Hôpital Saint-Joseph | 100 | 2015-11-01 | 2017-09-08 | |
| Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption Oxymetazoline - Dental Anesthesia, Nasal Surgical Procedures | Phase 2 | Withdrawn | Richard Cartabuke | 2014-06-01 | 2015-08-07 |
Cleft Lip (1) · Emergence Delirium (1) · Nasal Obstruction (1)
Airway Obstruction (1) · Confusion (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Delirium (1) · Lip Diseases (1) · Mental Disorders (1) · Mouth Abnormalities (1) · Mouth Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1)
Cephalexin (1) · Clindamycin (1) · Oxymetazoline (1) · remimazolam (1)
East Tennessee Children's Hospital (1) · Fondation Hôpital Saint-Joseph (1) · Jeju National University School of Medicine (1) · Mayo Clinic (1) · Richard Cartabuke (1) · Stanford University (1)
United States (4) · France (1) · South Korea (1)
Brittany Howard, MD (1) · Richard Cartabuke, MD (1) · Sam P Most, MD (1)